Offer - Urjas Oil for just ₹ 1
Topocan 2.5 Injection, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Ovarian Cancer. Other than this, Topocan 2.5 Injection has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Topocan 2.5 Injection is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The most common side effects of Topocan 2.5 Injection are Fatigue, Nausea or vomiting, Headache. Besides the aforementioned side effects, there are other adverse effects of Topocan 2.5 Injection as well, which are listed below. Such side effects of Topocan 2.5 Injection normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Topocan 2.5 Injection's effect during pregnancy is Severe and Severe while nursing. Warnings related to Topocan 2.5 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Topocan 2.5 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Topocan 2.5 Injection in conditions like Anemia, Herpes, Lung Cancer.
Drug interactions for Topocan 2.5 Injection have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Topocan 2.5 Injection is considered not safe while driving, and is not addictive.
Topocan 2.5 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
| Adult |
|
| Geriatric |
|
Is the use of Topocan 2.5 Injection safe for pregnant women?
Topocan has many dangerous side effects in pregnant women. If you are pregnant, do not consume Topocan without medical advice.
Is the use of Topocan 2.5 Injection safe during breastfeeding?
Taking Topocan may lead to serious side effects if you are breastfeeding. Topocan should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Topocan 2.5 Injection on the Kidneys?
Topocan has very mild side effects on the kidneys.
What is the effect of Topocan 2.5 Injection on the Liver?
Using Topocan does not have any harmful effects on the liver.
What is the effect of Topocan 2.5 Injection on the Heart?
Using Topocan does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Topocan 2.5 Injection unless your doctor advises you to do so -
Is this Topocan 2.5 Injection habit forming or addictive?
Topocan 2.5 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Topocan 2.5 Injection, you should not drive or work on any heavy machine, as Topocan 2.5 Injection can make you drowsy.
Is it safe?
Topocan 2.5 Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
Topocan 2.5 Injection is unable to treat or cure mental disorders.
Interaction between Food and Topocan 2.5 Injection
Taking Topocan 2.5 Injection with food does not harm your health.
Interaction between Alcohol and Topocan 2.5 Injection
It is difficult to say anything about the effect of Topocan 2.5 Injection and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Topotecan
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1221-1223
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 866
